Viridian Therapeutics, Inc. (VRDN)
NASDAQ: VRDN · Real-Time Price · USD
13.49
-0.07 (-0.52%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Viridian Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Cash & Equivalents | 99.59 | 102.83 | 155.58 | 42.3 | 45.9 | Upgrade
|
| Short-Term Investments | 617.99 | 374.54 | 268.97 | 154.67 | 81.74 | Upgrade
|
| Cash & Short-Term Investments | 717.58 | 477.37 | 424.55 | 196.97 | 127.64 | Upgrade
|
| Cash Growth | 50.32% | 12.44% | 115.55% | 54.31% | 375.47% | Upgrade
|
| Receivables | - | 0.1 | 0.1 | 0.45 | - | Upgrade
|
| Prepaid Expenses | 20.88 | 9.01 | 6.52 | 2.65 | 1.97 | Upgrade
|
| Other Current Assets | - | - | - | 0.1 | - | Upgrade
|
| Total Current Assets | 738.46 | 486.48 | 431.17 | 200.16 | 129.61 | Upgrade
|
| Property, Plant & Equipment | 3.44 | 3.34 | 2.94 | 2.06 | 0.79 | Upgrade
|
| Other Long-Term Assets | 0.5 | 0.6 | 0.98 | 1.49 | 0.86 | Upgrade
|
| Total Assets | 742.4 | 490.42 | 435.09 | 203.71 | 131.26 | Upgrade
|
| Accounts Payable | 2.14 | 2.24 | 14.23 | 2.33 | 0.67 | Upgrade
|
| Accrued Expenses | 44.83 | 23.17 | 18.11 | 10.4 | 9.06 | Upgrade
|
| Current Portion of Leases | 0.51 | 0.84 | 0.61 | 0.52 | 0.46 | Upgrade
|
| Current Unearned Revenue | 0.29 | 0.29 | 0.29 | 0.29 | 0.3 | Upgrade
|
| Other Current Liabilities | 0.1 | 0.1 | 0.1 | 0.1 | 0.19 | Upgrade
|
| Total Current Liabilities | 47.87 | 26.64 | 33.35 | 13.64 | 10.67 | Upgrade
|
| Long-Term Debt | 20.58 | 20.21 | 4.65 | - | - | Upgrade
|
| Long-Term Leases | 2.02 | 0.99 | - | - | - | Upgrade
|
| Long-Term Unearned Revenue | 0.28 | 0.57 | 0.86 | 1.15 | - | Upgrade
|
| Other Long-Term Liabilities | - | - | 1.17 | 1.21 | 0.54 | Upgrade
|
| Total Liabilities | 70.76 | 48.4 | 40.03 | 15.99 | 11.22 | Upgrade
|
| Common Stock | 0.81 | 0.54 | 0.41 | 0.24 | 0.04 | Upgrade
|
| Additional Paid-In Capital | 1,478 | 960.54 | 741.07 | 412.1 | 218.09 | Upgrade
|
| Retained Earnings | -995.86 | -725.91 | -488.17 | -358.3 | -278.89 | Upgrade
|
| Comprehensive Income & Other | -0.01 | 0.34 | -0.39 | -0.16 | -0.01 | Upgrade
|
| Total Common Equity | 482.75 | 235.51 | 252.92 | 53.88 | -60.76 | Upgrade
|
| Shareholders' Equity | 671.64 | 442.02 | 395.06 | 187.72 | 120.04 | Upgrade
|
| Total Liabilities & Equity | 742.4 | 490.42 | 435.09 | 203.71 | 131.26 | Upgrade
|
| Total Debt | 23.12 | 22.04 | 5.26 | 0.52 | 0.46 | Upgrade
|
| Net Cash (Debt) | 694.47 | 455.33 | 419.29 | 196.45 | 127.18 | Upgrade
|
| Net Cash Growth | 52.52% | 8.60% | 113.44% | 54.46% | 585.96% | Upgrade
|
| Net Cash Per Share | 10.23 | 10.17 | 13.07 | 16.48 | 35.76 | Upgrade
|
| Filing Date Shares Outstanding | 81.48 | 62.77 | 42.9 | 25.91 | 7.23 | Upgrade
|
| Total Common Shares Outstanding | 80.99 | 53.99 | 41.31 | 23.92 | 4.23 | Upgrade
|
| Working Capital | 690.59 | 459.84 | 397.82 | 186.53 | 118.94 | Upgrade
|
| Book Value Per Share | 5.96 | 4.36 | 6.12 | 2.25 | -14.36 | Upgrade
|
| Tangible Book Value | 482.75 | 235.51 | 252.92 | 53.88 | -60.76 | Upgrade
|
| Tangible Book Value Per Share | 5.96 | 4.36 | 6.12 | 2.25 | -14.36 | Upgrade
|
| Machinery | 2.25 | 2.05 | 2.22 | 1.4 | 3.01 | Upgrade
|
| Leasehold Improvements | 0.25 | 0.67 | 1.11 | 0.75 | 0.74 | Upgrade
|
Updated Mar 3, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.